KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Intangibles (2016 - 2025)

Idexx Laboratories has reported Intangibles over the past 17 years, most recently at $109.8 million for Q4 2025.

  • Quarterly results put Intangibles at $109.8 million for Q4 2025, down 1.64% from a year ago — trailing twelve months through Dec 2025 was $109.8 million (down 1.64% YoY), and the annual figure for FY2025 was $109.8 million, down 1.64%.
  • Intangibles for Q4 2025 was $109.8 million at Idexx Laboratories, down from $114.8 million in the prior quarter.
  • Over the last five years, Intangibles for IDXX hit a ceiling of $115.4 million in Q1 2024 and a floor of $54.0 million in Q1 2021.
  • Median Intangibles over the past 5 years was $100.3 million (2022), compared with a mean of $99.3 million.
  • Biggest five-year swings in Intangibles: soared 94.9% in 2022 and later fell 13.49% in 2023.
  • Idexx Laboratories' Intangibles stood at $99.0 million in 2021, then decreased by 1.38% to $97.7 million in 2022, then decreased by 13.49% to $84.5 million in 2023, then soared by 32.16% to $111.7 million in 2024, then decreased by 1.64% to $109.8 million in 2025.
  • The last three reported values for Intangibles were $109.8 million (Q4 2025), $114.8 million (Q3 2025), and $103.7 million (Q2 2025) per Business Quant data.